Clinical Trial Update: SV-BR-1-GM in Metastatic or Locally Recurrent Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating SV-BR-1-GM in metastatic or locally recurrent breast cancer has completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• SV-BR-1-GM

Snippet

Sponsor: BriaCell Therapeutics Corporation | Conditions: Breastcancer, Breast Neoplasm | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-01-29